Pulmonary hypertension risk increases with the severity of CKD, and affects up to two-thirds of patients receiving hemodialysis.

Cardiogenic shock is frequently complicated by acute kidney injury, so investigators set out to identify predictors.

Drug-induced acute kidney injury (AKI) frequently develops in hospitalized patients receiving nephrotoxic therapy.

Researchers report results from a post hoc analysis evaluating the treatment response of sibeprenlimab vs placebo across different proteinuria thresholds in patients with IgA nephropathy.

Researchers report the impact of sparsentan vs irbesartan on proteinuria in patients with focal segmental glomerulosclerosis.

Review authors suggested guidelines to help in standardizing future lupus nephritis studies. Heterogeneity in lupus nephritis (LN) trial design substantially hinders interpretation of studied drugs’ ...

The longitudinal assessment of albuminuria appears critical for assessing MACE risk in patients with and without CKD. The ...

In the current study, investigators aimed to assess longitudinal trends in kidney disease-related deaths and temperature in the US. They analyzed data from the 2010-2020 US Centers for Disease Control ...

Investigators examined the prevalence of aluminum-containing medication exposure among patients on hemodialysis with diagnoses potentially attributable to aluminum toxicity.

Among hospitalized patients with septic shock, those with vs without low serum chloride levels or requirement for continuous renal replacement therapy (CRRT) have higher mortality ...

Investigators studied response to standard chronic kidney disease (CKD) therapies among real-world patients with monogenic forms of glomerular disease.

High-dose tirzepatide is associated with superior HbA1c reduction and weight loss compared with semaglutide in type 2 diabetes and obesity.